We lost 51,000 jobs, unemoloyment rate is now 5.7
This was better then expected on the jobs front
Friday, August 1, 2008
Thursday, July 31, 2008
ELAN - ELN - Tysabri Drug goes wrong!
Tonight Elan ( ELN ) is down another 35% as the company released an SEC filing stating that two patients taking Tysabri were infected with the rare PML brain disorder.
These two incidents happened today and yesterday....both patients are in Europe....one still hospitalized, the other is at home and clinically stable.
Elan was $32 just days ago and now has fallen to $11.50 afterhours tonight.
ELN has strong support in the $7 range so if it got there it might be interesting. This is fresh news so tomorrow I will look to see how the market takes this news.
Watching my level 2 trading....i'm seeing big blocks coming in for sale: 500,000 share blocks coming in hitting the bidders. Not a good sign!!
ELN could trade between 80-120 million shares tomorrow I would guess. Who knows maybe more! Keep this stock on your watchlists.
Please note: Biogen Idec ( BIIB ) is also a partner for this drug
http://www.sec.gov/Archives/edgar/data/737572/000095016208000315/elan6k_073108.htm
These two incidents happened today and yesterday....both patients are in Europe....one still hospitalized, the other is at home and clinically stable.
Elan was $32 just days ago and now has fallen to $11.50 afterhours tonight.
ELN has strong support in the $7 range so if it got there it might be interesting. This is fresh news so tomorrow I will look to see how the market takes this news.
Watching my level 2 trading....i'm seeing big blocks coming in for sale: 500,000 share blocks coming in hitting the bidders. Not a good sign!!
ELN could trade between 80-120 million shares tomorrow I would guess. Who knows maybe more! Keep this stock on your watchlists.
Please note: Biogen Idec ( BIIB ) is also a partner for this drug
http://www.sec.gov/Archives/edgar/data/737572/000095016208000315/elan6k_073108.htm
Earnings 7-31 4pm - CHK, HNSN, BOOM
Last night we had great earnings from Visa and First solar....Akamai disappointed and it is getting killed today just like Garmin on Wednesday.
Tonight we have Earnings from Chesapeake Energy, Hansen Medical, Dynamic Materials.
Chesapeake Energy ( CHK ) - We already know their earnings might be effected by hedges they put on for the quarter relating to natural gas prices. I want to see what they say about their Shale positions, especially their Haynesville Shale play.
Dynamic Materials ( BOOM ) - I have been following this company since 2004-2005 when it was $3....have been in and out of it several times. This company has a product called explosive metal cladding....this is used on a number of things especially ships. Over the past year the blow out earnings quarters have tamed down. This is a stock to watch.
Hansen Medical ( HNSN ) Are you familiar with Intuitive Surgical ( ISRG )? The founder of ISRG, Dr. Moll, took HNSN public in late 2006. Hansen offers Sensei Robotic Catheter System, which is designed to allow physicians to navigate flexible catheters with stability and control in interventional procedures. They had no revenues last year but now are quietly selling these machines. This company will explode once they start making a profit. ( Similar to ENER..but different sector ) Keep an eye on this stock!
Tonight we have Earnings from Chesapeake Energy, Hansen Medical, Dynamic Materials.
Chesapeake Energy ( CHK ) - We already know their earnings might be effected by hedges they put on for the quarter relating to natural gas prices. I want to see what they say about their Shale positions, especially their Haynesville Shale play.
Dynamic Materials ( BOOM ) - I have been following this company since 2004-2005 when it was $3....have been in and out of it several times. This company has a product called explosive metal cladding....this is used on a number of things especially ships. Over the past year the blow out earnings quarters have tamed down. This is a stock to watch.
Hansen Medical ( HNSN ) Are you familiar with Intuitive Surgical ( ISRG )? The founder of ISRG, Dr. Moll, took HNSN public in late 2006. Hansen offers Sensei Robotic Catheter System, which is designed to allow physicians to navigate flexible catheters with stability and control in interventional procedures. They had no revenues last year but now are quietly selling these machines. This company will explode once they start making a profit. ( Similar to ENER..but different sector ) Keep an eye on this stock!
Wednesday, July 30, 2008
Earnings 7-30 4pm - Visa ( V ) First Solar ( FSLR ) Akamai ( AKAM )
After a great night last night from BWLD, Garmin came in with some very bad news this morning on their Nuvifone delay.
Tonight we have a number of companies due to report earnings
Visa (V) - Analysts are expecting Visa to earn .48 cents per share. This stock has really run up going into earnings but I expect a good report. How the stock reacts is a totally different story. Last quarter Visa was down big after the earnings release...opened the next day at $71....ran the whole day and closed near $78. They earned .52 cents last quarter.
First Solar (FSLR) - Analysts are expecting First Solar to earn .58 cents a share. FSLR is trading at a very high p/e ratio so any miss or guidance miss would be a huge disappointment and you would see FSLR really go down. If they come out and beat, and then raise...you could see First Solar really break out.
Akamai ( AKAM ) - I really like this company....Akamai basically powers the internet with their technology. Most of the Video that runs on the Internet is powered by Akamai.
That website shows you the traffic through Akamai system....it has basically doubled from a year ago. Earnings Guidance will be key tonight...so watch AKAM
Tonight we have a number of companies due to report earnings
Visa (V) - Analysts are expecting Visa to earn .48 cents per share. This stock has really run up going into earnings but I expect a good report. How the stock reacts is a totally different story. Last quarter Visa was down big after the earnings release...opened the next day at $71....ran the whole day and closed near $78. They earned .52 cents last quarter.
First Solar (FSLR) - Analysts are expecting First Solar to earn .58 cents a share. FSLR is trading at a very high p/e ratio so any miss or guidance miss would be a huge disappointment and you would see FSLR really go down. If they come out and beat, and then raise...you could see First Solar really break out.
Akamai ( AKAM ) - I really like this company....Akamai basically powers the internet with their technology. Most of the Video that runs on the Internet is powered by Akamai.
That website shows you the traffic through Akamai system....it has basically doubled from a year ago. Earnings Guidance will be key tonight...so watch AKAM
Garmin GRMN Earnings - Nuvifone delayed - FNM, FRE Stocks
This morning Garmin reported $1.19 per share, alot higher then expected. Revenues were a little light. They are cutting guidance and delaying their nuvifone until the first half of 2009. Very Bad News!
Other news, BWLD Buffalo Wild Wings beat earnings last night and the stock is up 10% today.
Freddie Mac ( FRE ) and Fannie Mae ( FNM ) are also set to move higher in pre market.
Other news, BWLD Buffalo Wild Wings beat earnings last night and the stock is up 10% today.
Freddie Mac ( FRE ) and Fannie Mae ( FNM ) are also set to move higher in pre market.
Tuesday, July 29, 2008
Earnings 7/29: Stock to Watch - BWLD, GMKT, USO
After a fairly good earnings release from Continetal Resources CLR this morning, the stock has gotten killed but is bouncing off the lows this afternoon. CLR gave positive comments about their Bakken Shale play
Tonight we get earnings reports from Buffalo Wild Wings ( BWLD )
BWLD is expected to earn .27 cents per share. BWLD has usually moved 5-10% on earnings.
Another stock to watch tonight 7/29/08 is Gmarket ( GMKT ).
GMKT is expected to earn .21 cents per share.
These two stocks will be very active tomorrow.
Oil is bouncing off the lows this afternoon....currently at $122.50....the USO just spiked $1 to $99.50...we will have to see where it closes!
Tonight we get earnings reports from Buffalo Wild Wings ( BWLD )
BWLD is expected to earn .27 cents per share. BWLD has usually moved 5-10% on earnings.
Another stock to watch tonight 7/29/08 is Gmarket ( GMKT ).
GMKT is expected to earn .21 cents per share.
These two stocks will be very active tomorrow.
Oil is bouncing off the lows this afternoon....currently at $122.50....the USO just spiked $1 to $99.50...we will have to see where it closes!
New Technical Analysis Charts, Visa ( V ) Apple (AAPL) RIMM
This morning in premarket you will want to watch CLR as they reported some nice earnings. Earnings reports continue to come out...so far they are so so.
As for the Dow, I think we will retest the lows in the coming weeks just to see whats there. If we break the lows on a closing basis, look out below!
Here are some new technical analysis stock charts....I will continue to update my regular stock charts.
As for the Dow, I think we will retest the lows in the coming weeks just to see whats there. If we break the lows on a closing basis, look out below!
Here are some new technical analysis stock charts....I will continue to update my regular stock charts.
Monday, July 28, 2008
Sohu.com Earnings - Amgen - AMGN
This Monday morning we have great numbers out of Sohu.com. Expectations were for SOHU to come in with .66 EPS and SOHU came in with $1.02 or Non Gapp of $1.07. Just incredible numbers!.
Amgen AMGN will also be a big mover today as on Friday evening they released positive bone drug data.
For more on upcoming earnings....visit blackberrystocks.com
For the lastest company updates in relation to the haynesville shale....visit OilShaleGas.com
Amgen AMGN will also be a big mover today as on Friday evening they released positive bone drug data.
For more on upcoming earnings....visit blackberrystocks.com
For the lastest company updates in relation to the haynesville shale....visit OilShaleGas.com
Friday, July 25, 2008
XTO Energy XTO - John Najarian CNBC - Shale
John Najarian has come on CNBC this morning and states that yesterday XTO has seen very active call buying and institutional buying the last couple days.
He stated the last time XTO Energy was this low....crude oil was in the $70's. He said if you want to play crude in a stock...this is the way to do it...usually it moves 2-1 higher or lower.
He also stated that XTO has been active in the Shale Plays which we already know!
XTO is active in the Following Shale Plays
Bakken Shale
Haynesville Shale
Marcellus Shale
Barnett Shale
He stated the last time XTO Energy was this low....crude oil was in the $70's. He said if you want to play crude in a stock...this is the way to do it...usually it moves 2-1 higher or lower.
He also stated that XTO has been active in the Shale Plays which we already know!
XTO is active in the Following Shale Plays
Bakken Shale
Haynesville Shale
Marcellus Shale
Barnett Shale
EPCT - Epicept up 200% Pre Market Drug Approval
Today ECPT - Epicept is up over 200% on approval of Ceplene, one of their drugs.
Ceplene(R) Receives Positive European Opinion for Approval From CHMP
Marketing Authorization Normally Anticipated within 67 Days in the EU
Conference Call to be Held July 28 at 9:00 a.m. Eastern Time
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion regarding the marketing authorization for Ceplene® (histamine dihydrochloride), for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission. Ceplene is to be administered in conjunction with low-dose interleukin-2 (IL-2). This positive opinion was issued following a request made by EpiCept to have the initial negative opinion of March 2008 re-examined by the CHMP. Ceplene has been designated as an orphan medicinal product, and as such is entitled to 10 years of marketing exclusivity in the EU
Ceplene(R) Receives Positive European Opinion for Approval From CHMP
Marketing Authorization Normally Anticipated within 67 Days in the EU
Conference Call to be Held July 28 at 9:00 a.m. Eastern Time
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion regarding the marketing authorization for Ceplene® (histamine dihydrochloride), for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission. Ceplene is to be administered in conjunction with low-dose interleukin-2 (IL-2). This positive opinion was issued following a request made by EpiCept to have the initial negative opinion of March 2008 re-examined by the CHMP. Ceplene has been designated as an orphan medicinal product, and as such is entitled to 10 years of marketing exclusivity in the EU
Subscribe to:
Posts (Atom)
